Stevanato Group

OtterBox Launches Defender Series XT Division 2 for Use in Hazardous Locations

Retrieved on: 
Monday, November 13, 2023
IPhone 14, Agriculture, Safety, OtterBox, Dust, Stevanato Group, Smartphone, Mining, United, Division II, Gas, Communication, Aviation, IPhone, MagSafe, Risk management, Explosive

FORT COLLINS, Colo., Nov. 13, 2023 /PRNewswire/ -- OtterBox, the #1 most trusted smartphone case brand in the U.S., introduces its latest industrial focused solution: Defender Series XT Division 2 for iPhone 14. This ultra-rugged, device-integrated protective case is certified by UL Solutions and developed to safeguard tech in certain hazardous locations, helping to improve worksite safety and efficiency in harsh environments.

Key Points: 
  • FORT COLLINS, Colo., Nov. 13, 2023 /PRNewswire/ -- OtterBox, the #1 most trusted smartphone case brand in the U.S., introduces its latest industrial focused solution: Defender Series XT Division 2 for iPhone 14.
  • "Defender Series XT Division 2 advances our portfolio of device-integrated case solutions designed and third-party certified for use in challenging environments," said OtterBox Chief Commercial Officer Berkley Fuller.
  • "Appropriately protected mobile solutions enable the use of digital tools and technology which can increase safety, communication, convenience and efficiency for workers at industrial locations, and OtterBox is proud to offer Defender Series XT Division 2 to meet that need."
  • Defender Series XT Division 2 for iPhone 14 joins the OtterBox portfolio of industrial-grade solutions, including Hardline Series.

Pre-Sterilized/Ready to Use Pharmaceutical Packaging Market, 2035 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 24, 2023
Health, Pharmaceutical, Type, Elastomer, FDA, Biomedical Advanced Research and Development Authority, AptarGroup, Vaccine, Container, SCHOTT, Dätwyler, West Pharmaceutical Services, Glass, BARDA, Development, Growth, COVID-19, RTU, Duran (glass), EMA, Porta Nuova (Milan), Safety, Material, EZ, Investment, Syringe, Value proposition, Patient safety, Sterilization, Medical device, Fine chemical, Borosilicate glass, Stevanato Group

This focus on product safety has given rise to the adoption of pre-sterilized or ready-to-use containers and closures in pharmaceutical packaging.

Key Points: 
  • This focus on product safety has given rise to the adoption of pre-sterilized or ready-to-use containers and closures in pharmaceutical packaging.
  • It's essential to highlight that the growing demand for secure drug delivery systems has fueled the expansion of the global pharmaceutical packaging market.
  • The integration of ready-to-use (RTU) packaging containers in the pharmaceutical sector enables expedited product launches through an optimized value chain.
  • The current landscape of pre-sterilized / ready to use pharmaceutical primary packaging features close to 95 RTU containers and 85 RTU closures.

Pre-Sterilized/Ready to Use Pharmaceutical Packaging Market Size to Expand Lucratively and Reach $14.23 Bn to 2031 - Explained Details | Updated InsightAce Study

Retrieved on: 
Wednesday, October 25, 2023
FDA, Biomedical Advanced Research and Development Authority, AptarGroup, Vaccine, Government, ATMP, SCHOTT, Dätwyler, West Pharmaceutical Services, BARDA, Development, Growth, Schott, COVID-19, RTU, Duran (glass), EMA, Nuova Cometra, SGD, Medication, Investment, Patient safety, Medical device, Beauty salon, Stevanato Group

The main factors responsible for driving the Pre-Sterilized/Ready to Use Pharmaceutical packaging market are increasing preference towards patient safety and rising importance for sterility and integrity of pharmaceutical products.

Key Points: 
  • The main factors responsible for driving the Pre-Sterilized/Ready to Use Pharmaceutical packaging market are increasing preference towards patient safety and rising importance for sterility and integrity of pharmaceutical products.
  • In addition, strict regulatory guidelines set by regulatory agencies such as the FDA and EMA play an essential role in booming the demand for pre-sterilized pharmaceutical packaging.
  • The addition of RTU (ready-to-use) packaging into the pharmaceutical industry ensures that the product is quickly available through the optimized supply chain.
  • Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Container
    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Closure

Pre-Sterilized/Ready to Use Pharmaceutical Packaging Market Size to Expand Lucratively and Reach $14.23 Bn to 2031 - Explained Details | Updated InsightAce Study

Retrieved on: 
Wednesday, October 25, 2023
FDA, Biomedical Advanced Research and Development Authority, AptarGroup, Vaccine, Government, ATMP, SCHOTT, Dätwyler, West Pharmaceutical Services, BARDA, Development, Growth, Schott, COVID-19, RTU, Duran (glass), EMA, Nuova Cometra, SGD, Medication, EZ, Investment, Patient safety, Medical device, Beauty salon, Stevanato Group

The main factors responsible for driving the Pre-Sterilized/Ready to Use Pharmaceutical packaging market are increasing preference towards patient safety and rising importance for sterility and integrity of pharmaceutical products.

Key Points: 
  • The main factors responsible for driving the Pre-Sterilized/Ready to Use Pharmaceutical packaging market are increasing preference towards patient safety and rising importance for sterility and integrity of pharmaceutical products.
  • In addition, strict regulatory guidelines set by regulatory agencies such as the FDA and EMA play an essential role in booming the demand for pre-sterilized pharmaceutical packaging.
  • The addition of RTU (ready-to-use) packaging into the pharmaceutical industry ensures that the product is quickly available through the optimized supply chain.
  • Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Container
    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Type of Closure

PDA Announces 2023 Drug Delivery Innovation Award Winners at Universe of Pre-Filled Syringes Conference

Retrieved on: 
Tuesday, October 17, 2023
Universe, Chicago Innovation Awards, Partnership, ANSI, Stevanato Group, Parenteral Drug Association, PDA, Automation, Caregiver, WMG, University of Warwick, Digital platform, Global Smoke-Free Partnership Award, Organization, Limited partnership, Bayer, Ecosystem, Education, Merck, Science, PFS, Syringe, Patient, Diluent, Pharmaceutical industry, EU

BETHESDA, Md., Oct. 17, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the winners of the 2023 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices conference in Gothenburg, Sweden. Awardees were recognized for their technical innovations in advancing the field of bio/pharmaceutical manufacturing.

Key Points: 
  • BETHESDA, Md., Oct. 17, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the winners of the 2023 PDA Drug Delivery Innovation Awards during the opening plenary session of the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices conference in Gothenburg, Sweden.
  • The companies recognized for the 2023 PDA Drug Delivery Innovation Awards are well-deserving of this honor and I congratulate them for their achievements and tireless effort to move the industry forward.
  • PDA recognizes the award winners each year at its annual Universe of Pre-Filled Syringes and Injection Devices conference, which is held in the U.S. in even years and the EU in odd years.
  • The PDA Drug Delivery Innovation Awards were created in 2019 to recognize technical innovations advancing the field of bio/pharmaceutical manufacturing.

Europe Vaccine Packaging Market Insights Report 2023-2028 Featuring Key vendors - SCHOTT, Gerresheimer, Stevanato Group, Amcor, SGD Pharma, WestRock, & Corning Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, July 3, 2023
Packaging, Pharmaceutical, Health, Manufacturing, Vaccine, Drug development, Prevalence, WestRock, Ageing, Research, Infection, Sale, Amcor, Stevanato Group, Growth, SGD, R, Rare, SCHOTT, Glass, Autoimmunity, Syringe

This report offers market size & forecast data for the European vaccine packaging market.

Key Points: 
  • This report offers market size & forecast data for the European vaccine packaging market.
  • This report provides a comprehensive and current market scenario of Europe vaccine packaging, including the market size, anticipated market forecast, relevant market segmentations, and industry trends.
  • Based on primary packaging type, the vials packaging segment accounted for a 38.18% market share in the Europe vaccine packaging market.
  • SCHOTT, Gerresheimer AG, Stevanato Group, Amcor, SGD Pharma, WestRock, Corning Incorporation, and Others are the leading players in the Europe vaccine Packaging market.

Stevanato Group Presents Vertiva™, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (up to 10mL)

Retrieved on: 
Monday, June 12, 2023
Packaging, Medical Supplies, Health, Medical Devices, Manufacturing, Pharmaceutical, Biotechnology, Injection, Drug development, ISO, Multimedia, Thermo Fisher Scientific, Vaccine, Patient, Stevanato Group, Administration, NYSE, Pharmaceutical industry, Online shopping

The device can adapt to different delivery profiles and can enable the administration of small-molecule drugs and biologics.

Key Points: 
  • The device can adapt to different delivery profiles and can enable the administration of small-molecule drugs and biologics.
  • Vertiva™ ‘s design is under development also to cover a broad range of volumes up to 10mL.
  • Vertiva™ platform can also accommodate different customizations, including primary packaging format for larger injection volumes, delivery duration, and user interface.
  • Stevanato Group will leverage the recently announced collaboration with Thermo Fisher Scientific to bring Vertiva™ to market.

Asia-Pacific Vaccine Packaging Market Report 2023: A $1.149 Billion Market by 2028 from $695 Million in 2022 with China Dominating - ResearchAndMarkets.com

Retrieved on: 
Friday, June 9, 2023
Packaging, Pharmaceutical, Health, Manufacturing, Vaccine, Drug development, Prevalence, WestRock, Ageing, Research, Infection, Sale, Amcor, Stevanato Group, Growth, SGD, R, Rare, SCHOTT, Glass, Autoimmunity, Syringe, Pharmaceutical industry

The APAC vaccine packaging market was valued at $695.54 million in 2022 and is projected to reach $1,149.38 million in 2028, with a compound annual growth rate (CAGR) of 8.73%, during the study period.

Key Points: 
  • The APAC vaccine packaging market was valued at $695.54 million in 2022 and is projected to reach $1,149.38 million in 2028, with a compound annual growth rate (CAGR) of 8.73%, during the study period.
  • This report offers market size & forecast data for the vaccine packaging market in APAC.
  • This report provides a comprehensive and current market scenario of the APAC vaccine packaging, including the APAC vaccine packaging market size, anticipated market forecast, relevant market segmentations, and industry trends.
  • The study considers a detailed scenario of the present vaccine packaging market and its market dynamics for 2023-2028 in APAC.

United States Vaccine Packaging Market 2023 - 2028: Substantial Involvement of Government in Vaccination Programs Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 1, 2023
Packaging, Pharmaceutical, Health, Manufacturing, Vaccine, Drug development, Prevalence, WestRock, Ageing, Research, Infection, Sale, Government, Amcor, Investment, Stevanato Group, SGD, R, Rare, Transport, SCHOTT, Glass, Autoimmunity, Syringe, Pharmaceutical industry

This report offers market size & forecast data for the vaccine packaging market in the US.

Key Points: 
  • This report offers market size & forecast data for the vaccine packaging market in the US.
  • This report provides a comprehensive and current US vaccine packaging market scenario, including the US vaccine packaging market size, anticipated market forecast, relevant market segmentations, and industry trends.
  • The study considers a detailed scenario of the present vaccine packaging market and its market dynamics for 2023-2028 in the US.
  • Based on primary packaging type, the vials packaging segment accounted for a 38.13% market share in the US vaccine packaging market.

Owen Mumford Wins Distinction in Red Dot Award (Product Design 2023) for Aidaptus® Auto-Injector

Retrieved on: 
Tuesday, April 18, 2023
Product design, Drug development, Biotechnology, Red Dot, BREEAM, History, Multiple sclerosis, Patient, Risk, OMPS, Stevanato Group, Glass, News, Rheumatoid arthritis, Syringe, Pharmaceutical industry

Aidaptus wins the Red Dot award for the category Product Design 2023.

Key Points: 
  • Aidaptus wins the Red Dot award for the category Product Design 2023.
  • “Red Dot is one of the most prestigious design competitions that is highly competitive, and we are honoured to be globally recognised with distinction in the Product Design 2023 category,” said Jarl Severn, CEO Owen Mumford.
  • With around 20,000 entries per year, the Red Dot Design Award is one of the biggest design competitions in the world.
  • The “Red Dot” accolade has become established internationally as one of the most sought-after seals of quality for good design.